Matthias Gerlach

524 total citations
26 papers, 442 citations indexed

About

Matthias Gerlach is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Matthias Gerlach has authored 26 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 11 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Matthias Gerlach's work include Synthesis and biological activity (9 papers), Synthesis and Biological Evaluation (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Matthias Gerlach is often cited by papers focused on Synthesis and biological activity (9 papers), Synthesis and Biological Evaluation (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Matthias Gerlach collaborates with scholars based in Germany, France and Ireland. Matthias Gerlach's co-authors include E Günther, Konrad J. Böhm, Yury P. Rakovich, Helge Prinz, Klaus Müller, John F. Donegan, Silke Baasner, Péter Schmidt, Eberhard Unger and Michael Reggelin and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Materials Chemistry.

In The Last Decade

Matthias Gerlach

25 papers receiving 432 citations

Peers

Countries citing papers authored by Matthias Gerlach

Since Specialization

Citations

This map shows the geographic impact of Matthias Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Gerlach more than expected).

Fields of papers citing papers by Matthias Gerlach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Gerlach. The network helps show where Matthias Gerlach may publish in the future.

Co-authorship network of co-authors of Matthias Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Gerlach. A scholar is included among the top collaborators of Matthias Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Gerlach. Matthias Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Cédric Logé, Marc Le Borgne, (unknown), (unknown), Babette Aicher, Michael Teifel, E Günther, Matthias Gerlach, Pascal Marchand	8
2	Discovery of 7‐Aryl‐Substituted (1,5‐Naphthyridin‐4‐yl)ureas as Aurora Kinase Inhibitors 2013 ·ChemMedChem ·(unknown), (unknown), Marc Le Borgne, (unknown), (unknown), Babette Aicher, Michael Teifel, E Günther, Matthias Gerlach, Pascal Marchand	10
3	Abstract 5476: LHRH receptor targeting as mechanism of anti-tumor activity for cytotoxic conjugates of Disorazol Z with the LHRH receptor agonistic peptide D-Lys6-LHRH. 2013 ·Cancer Research ·Babette Aicher, (unknown), Lars Blumenstein, Antje Schubert, Carsten Gründker, J. Engel, Olaf Ortmann, Rolf Mueller, (unknown), Matthias Gerlach, Michael Teifel	1
4	Abstract 871: Dual inhibition of PI3K and Erk1/2 shows synergy and efficacy in human tumor cells, either by using drug combinations or novel dual PI3K/Erk inhibitors 2012 ·Cancer Research ·(unknown), Matthias Gerlach, Lars Blumenstein, (unknown), (unknown), Jürgen Engel, Michael Teifel	3
5	ChemInform Abstract: A Convenient Synthesis of Novel 2,8‐Disubstituted Pyrido[3,4‐b]pyrazines Possessing Biological Activity. 2012 ·ChemInform ·(unknown), Matthias Gerlach, (unknown), (unknown), Michael Czech, (unknown), Pascal Marchand	1
6	Virtualisierung bei Eingebetteten Multicore Systemen: Integration und Isolation sicherheitskritischer Funktionen. 2011 ·Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) ·Robert Hilbrich, Matthias Gerlach	1
7	Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents—synthesis, antiproliferative activity and inhibition of tubulin polymerization 2011 ·Bioorganic & Medicinal Chemistry ·Helge Prinz, Péter Schmidt, Konrad J. Böhm, Silke Baasner, Klaus Müller, Matthias Gerlach, E Günther, Eberhard Unger	17
8	Abstract 3563: A highly selective Erk1/2 Inhibitor with in-vivo anti tumor potency 2011 ·Cancer Research ·(unknown), (unknown), Lars Blumenstein, (unknown), Péter Schmidt, Babette Aicher, Michael Teifel, Matthias Gerlach	1
9	ChemInform Abstract: Preparation of Novel 2,3,8‐Trisubstituted Pyrido[3,4‐b]pyrazines and Pyrido[2,3‐b]pyrazines. 2011 ·ChemInform ·(unknown), Michael Czech, Matthias Gerlach, (unknown), (unknown), Pascal Marchand	1
10	Electrochemiluminescence (ECL) sensing properties of water soluble core-shell CdSe/ZnS quantum dots/Nafion composite films 2011 ·Journal of Materials Chemistry ·Lynn Dennany, Matthias Gerlach, (unknown), Tia E. Keyes, Robert J. Forster, Paolo Bertoncello	71
11	Preparation of Novel 2,3,8-Trisubstituted Pyrido[3,4-b]pyrazines and Pyrido[2,3-b]pyrazines 2011 ·Synthesis ·Pascal Marchand, (unknown), Michael Czech, Matthias Gerlach, E Günther, (unknown)	6
12	A Convenient Synthesis of Novel 2,8-Disubstituted Pyrido[3,4-b]pyrazines Possessing Biological Activity 2011 ·Synthesis ·Pascal Marchand, (unknown), Matthias Gerlach, E Günther, (unknown), Michael Czech, (unknown)	18
13	Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety 2010 ·European Journal of Medicinal Chemistry ·(unknown), Péter Schmidt, Konrad J. Böhm, Silke Baasner, Klaus Müller, Matthias Gerlach, Eberhard Unger, E Günther, Helge Prinz	22
14	10-(2-oxo-2-Phenylethylidene)-10H-anthracen-9-ones as Highly Active Antimicrotubule Agents: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization 2009 ·Journal of Medicinal Chemistry ·Helge Prinz, Péter Schmidt, Konrad J. Böhm, Silke Baasner, Klaus Müller, Eberhard Unger, Matthias Gerlach, E Günther	26
15	Radiation-pressure-induced mode splitting in a spherical microcavity with an elastic shell 2007 ·Optics Express ·Matthias Gerlach, Yury P. Rakovich, John F. Donegan	19
16	Whispering gallery modes in photoluminescence and Raman spectra of a spherical microcavity with CdTe quantum dots: anti-Stokes emission and interference effects 2006 ·Nanoscale Research Letters ·Nikolai Gaponik, Yury P. Rakovich, Matthias Gerlach, John F. Donegan, Diana Savateeva, Andrey L. Rogach	12
17	4-Substituted-piperazin-1-yl-carbonyl-pyrazol derivatives: A new class of highly potent cytotoxic compounds with inhibitory effects on tubulin polymerization 2004 ·Cancer Research ·Silke Baasner, Matthias Gerlach, (unknown), Péter Schmidt, (unknown), E Günther	1
18	Design and Synthesis of a Focused Library of Novel Aryl‐ and Heteroaryl‐Ketopiperazides 2004 ·Archiv der Pharmazie ·Matthias Gerlach, (unknown), Silke Baasner, (unknown), (unknown), Péter Schmidt, E Günther, Jürgen Engel	5
19	Metallated 2-Alkenyl Sulfoximines in Asymmetric Synthesis: Regio- and Stereoselective Synthesis of Highly Substituted Oxabicyclic Ethers and Studies Towards the Total Syntheses of the Euglobals G1 and G2 and Arenaran A 1999 ·European Journal of Organic Chemistry ·Michael Reggelin, Matthias Gerlach, (unknown)	20
20	Metalated 2-Alkenylsulfoximines: Efficient Solutions for Asymmetric d³-Synthons 1996 ·Journal of the American Chemical Society ·Michael Reggelin, (unknown), Matthias Gerlach, (unknown)	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact